Stockreport

argenx Announces Publication of Translational Data of Efgartigimod in Autoimmune Skin Blistering Diseases

argenx SE - American Depositary Shares  (ARGX) 
PDF Translational data from Phase 2 study of efgartigimod in pemphigus further demonstrate argenx’s scientific leadership in FcRn biology, providing new insights into path [Read more]